Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

Carolyn Bolden-Watson, Michael A. Watson, Karl D. Murray, Paul J. Isackson, Elliott Richelson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We examined the effects of chronic (2 weeks) treatment with a typical neuroleptic, haloperidol (1 mg/kg, s.c.), and an atypical neuroleptic, clozapine (20 mg/kg, s.c.), on neurotensin receptor (NTR) mRNA levels by in situ hybridization histochemistry. Quantitative OD analysis showed haloperidol-induced NTR mRNA levels in the substantia nigra/ventral tegmental area (SN/ VTA) 110% over control levels (significant difference from the control, p < 0.05). In contrast, the same analysis applied to the sections from clozapine-treated animals showed no significant change in NTR mRNA levels compared with matched control sections (p > 0.05). Thus, chronic treatment with haloperidol but not clozapine resulted in elevated levels of NTR mRNA within the SN/VTA. These results suggest that the high incidence of extrapyramidal side effects of typical neuroleptics could result from changes in NTR expression in the SN/VTA.

Original languageEnglish (US)
Pages (from-to)1141-1143
Number of pages3
JournalJournal of Neurochemistry
Volume61
Issue number3
StatePublished - Sep 1993

Fingerprint

Neurotensin Receptors
Clozapine
Substantia Nigra
Haloperidol
Rats
Antipsychotic Agents
Messenger RNA
Ventral Tegmental Area
Level control
In Situ Hybridization
Incidence
Chemical analysis

Keywords

  • Atypical neuroleptics
  • Extrapyramidal side effects
  • In situ hybridization histochemistry

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Bolden-Watson, C., Watson, M. A., Murray, K. D., Isackson, P. J., & Richelson, E. (1993). Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra. Journal of Neurochemistry, 61(3), 1141-1143.

Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra. / Bolden-Watson, Carolyn; Watson, Michael A.; Murray, Karl D.; Isackson, Paul J.; Richelson, Elliott.

In: Journal of Neurochemistry, Vol. 61, No. 3, 09.1993, p. 1141-1143.

Research output: Contribution to journalArticle

Bolden-Watson, C, Watson, MA, Murray, KD, Isackson, PJ & Richelson, E 1993, 'Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra', Journal of Neurochemistry, vol. 61, no. 3, pp. 1141-1143.
Bolden-Watson C, Watson MA, Murray KD, Isackson PJ, Richelson E. Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra. Journal of Neurochemistry. 1993 Sep;61(3):1141-1143.
Bolden-Watson, Carolyn ; Watson, Michael A. ; Murray, Karl D. ; Isackson, Paul J. ; Richelson, Elliott. / Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra. In: Journal of Neurochemistry. 1993 ; Vol. 61, No. 3. pp. 1141-1143.
@article{23d67d5c9342427897f7f7e1373dff63,
title = "Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra",
abstract = "We examined the effects of chronic (2 weeks) treatment with a typical neuroleptic, haloperidol (1 mg/kg, s.c.), and an atypical neuroleptic, clozapine (20 mg/kg, s.c.), on neurotensin receptor (NTR) mRNA levels by in situ hybridization histochemistry. Quantitative OD analysis showed haloperidol-induced NTR mRNA levels in the substantia nigra/ventral tegmental area (SN/ VTA) 110{\%} over control levels (significant difference from the control, p < 0.05). In contrast, the same analysis applied to the sections from clozapine-treated animals showed no significant change in NTR mRNA levels compared with matched control sections (p > 0.05). Thus, chronic treatment with haloperidol but not clozapine resulted in elevated levels of NTR mRNA within the SN/VTA. These results suggest that the high incidence of extrapyramidal side effects of typical neuroleptics could result from changes in NTR expression in the SN/VTA.",
keywords = "Atypical neuroleptics, Extrapyramidal side effects, In situ hybridization histochemistry",
author = "Carolyn Bolden-Watson and Watson, {Michael A.} and Murray, {Karl D.} and Isackson, {Paul J.} and Elliott Richelson",
year = "1993",
month = "9",
language = "English (US)",
volume = "61",
pages = "1141--1143",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Haloperidol but not clozapine increases neurotensin receptor mRNA levels in rat substantia nigra

AU - Bolden-Watson, Carolyn

AU - Watson, Michael A.

AU - Murray, Karl D.

AU - Isackson, Paul J.

AU - Richelson, Elliott

PY - 1993/9

Y1 - 1993/9

N2 - We examined the effects of chronic (2 weeks) treatment with a typical neuroleptic, haloperidol (1 mg/kg, s.c.), and an atypical neuroleptic, clozapine (20 mg/kg, s.c.), on neurotensin receptor (NTR) mRNA levels by in situ hybridization histochemistry. Quantitative OD analysis showed haloperidol-induced NTR mRNA levels in the substantia nigra/ventral tegmental area (SN/ VTA) 110% over control levels (significant difference from the control, p < 0.05). In contrast, the same analysis applied to the sections from clozapine-treated animals showed no significant change in NTR mRNA levels compared with matched control sections (p > 0.05). Thus, chronic treatment with haloperidol but not clozapine resulted in elevated levels of NTR mRNA within the SN/VTA. These results suggest that the high incidence of extrapyramidal side effects of typical neuroleptics could result from changes in NTR expression in the SN/VTA.

AB - We examined the effects of chronic (2 weeks) treatment with a typical neuroleptic, haloperidol (1 mg/kg, s.c.), and an atypical neuroleptic, clozapine (20 mg/kg, s.c.), on neurotensin receptor (NTR) mRNA levels by in situ hybridization histochemistry. Quantitative OD analysis showed haloperidol-induced NTR mRNA levels in the substantia nigra/ventral tegmental area (SN/ VTA) 110% over control levels (significant difference from the control, p < 0.05). In contrast, the same analysis applied to the sections from clozapine-treated animals showed no significant change in NTR mRNA levels compared with matched control sections (p > 0.05). Thus, chronic treatment with haloperidol but not clozapine resulted in elevated levels of NTR mRNA within the SN/VTA. These results suggest that the high incidence of extrapyramidal side effects of typical neuroleptics could result from changes in NTR expression in the SN/VTA.

KW - Atypical neuroleptics

KW - Extrapyramidal side effects

KW - In situ hybridization histochemistry

UR - http://www.scopus.com/inward/record.url?scp=0027261520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027261520&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 1141

EP - 1143

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 3

ER -